Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Jean-Louis Chiasson

Abstract

To evaluate, in subjects with impaired glucose tolerance (IGT), the effect of acarbose on the incidence of diabetes, hypertension, and cardiovascular disease. The Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM) Trial was an international, multicenter, double-blind, placebo-controlled, randomized investigation, undertaken in 9 participating countries from December 1995 through August 2001. Patients were randomly assigned to receive placebo (N = 715) or acarbose, 100 mg three times a day (N = 714), and underwent follow-up for a mean of 3.3 years. Sixty-one subjects (4%) were excluded from the study because they did not have IGT or had no postrandomization data; thus, 1,368 subjects remained for intent-to-treat analysis. The outcome measures were the development of diabetes based on a single oral glucose tolerance test, the development of hypertension ((3) 140/90 mm Hg), and the development of major cardiovascular events, including coronary heart disease, cardiovascular death, stroke, and peripheral vascular disease. Two hundred eleven subjects in the acarbose-treated group and 130 in the placebo group discontinued treatment prematurely; however, they underwent follow-up for assessment of end points. Acarbose...Continue Reading

Associated Clinical Trials

References

Jan 1, 1991·American Heart Journal·K M AndersonW B Kannel
Dec 8, 1988·The New England Journal of Medicine·M F SaadP H Bennett
Dec 16, 1998·Diabetes Care·B Jönsson
Mar 10, 2001·Nature·S PuttermanK Weninger
Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Sep 27, 2002·Diabetes/metabolism Research and Reviews·Jay S Skyler, Carolyn Oddo
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trial Research Group
Nov 18, 2003·Diabetes, Obesity & Metabolism·S Haffner, H B Cassells
Dec 18, 2003·The American Journal of Medicine·Steven J Haffner, Holly Cassells

❮ Previous
Next ❯

Citations

Mar 28, 2008·International Urology and Nephrology·William Guy Herrington, Jeremy B Levy
Apr 18, 2008·Current Atherosclerosis Reports·Martial G Bourassa, Colin Berry
Oct 2, 2009·Current Diabetes Reports·Morali D Sharma, Alan J Garber
Jan 6, 2011·Diabetes, Obesity & Metabolism·D S H BellJ H O'Keefe
Jul 19, 2011·Journal of Clinical Biochemistry and Nutrition·Sirichai AdisakwattanaNatthakarn Wongsasiripat
Oct 20, 2010·International Journal of Molecular Sciences·Sarinya AkkarachiyasitSirichai Adisakwattana
Jan 23, 2013·The American Journal of Chinese Medicine·Yanbin GaoMingzheng Pan
Dec 10, 2009·Expert Opinion on Drug Safety·Katie S McClendonGabriel Ikponmosa Uwaifo
Aug 24, 2013·The American Journal of Medicine·Richard E Pratley
Jul 14, 2010·Cardiology Clinics·Sandeep A Saha, Katherine R Tuttle
Jul 7, 2009·Medical Hypotheses·Mark F McCartyFrancisco Contreras
Sep 5, 2008·Journal of Diabetes and Its Complications·Matteo Anselmino
Mar 21, 2007·Lancet·David S Ludwig
Feb 20, 2007·The American Journal of Cardiology·Gabriel I Uwaifo, Robert E Ratner
Jun 30, 2010·Fundamental & Clinical Pharmacology·Mariaelena LombardiGiuseppe M C Rosano
Jan 14, 2011·The American Journal of Medicine·Bernard Zinman
Apr 18, 2015·Journal of Traditional and Complementary Medicine·Richard A AndersonBarbara J Stoecker
Dec 26, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Monica Rosa LoizzoRosa Tundis
Aug 24, 2013·PloS One·Giang D NguyenMark F Mehler
Nov 16, 2018·The Nurse Practitioner·Christina Rariden
Mar 4, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sarinya AkkarachiyasitSirichai Adisakwattana
Jun 27, 2007·Journal of Pediatric Gastroenterology and Nutrition·Roberto Quezada-CalvilloBuford L Nichols
Nov 23, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·J Fagg, J Valabhji
Dec 15, 2010·Bioscience, Biotechnology, and Biochemistry·Kazuki MochizukiToshinao Goda
Mar 7, 2019·Nursing·Christina Rariden
Oct 22, 2009·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·D B CarrS R Heckbert
May 15, 2010·International Journal of Food Sciences and Nutrition·Monica R LoizzoFrancesco Menichini
May 24, 2011·International Journal of Food Sciences and Nutrition·Monica R LoizzoNatale Giuseppe Frega
Jun 23, 2007·The Journal of Nutrition·Roberto Quezada-CalvilloBuford L Nichols

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.